ISIS DE ARMAS: Open Payments
NPI 1386425015 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,250 in 52 payments from 11 companies in 2025. Trend: 2023 $125 · 2024 $814 · 2025 $1,250
Food & beverage: $1,250
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $317 |
| Axsome Therapeutics, Inc. | 5 | $243 |
| Lundbeck LLC | 5 | $135 |
| Otsuka America Pharmaceutical, Inc. | 5 | $134 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $121 |
| Alkermes, Inc. | 4 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $71 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Biogen, Inc. | 1 | $27 |
Products named: VRAYLAR, Auvelity, REXULTI, CAPLYTA, TRINTELLIX, ARISTADA, FANAPT, Jornay PM.
Industry payments across FL — which companies pay providers there.
